Pharmafile Logo
Pharmafocus logo
Advanced Search
parliemant

British pandemic strategy has been an “astonishing” failure, says cross-party parliamentary committee

July 23, 2020
Business Services COVID-19, coronavirus, pandemic

There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according …

News
800px-smallpox_vaccine

Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study

July 22, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma

BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …

News
fda

FDA sets out guidelines on cannabis derived drugs

July 22, 2020
Research and Development CBD, CBD Oil

The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs. The guidelines cover …

News
abbvie_0

AbbVie’s Rinvoq smashes Phase 3 efficacy targets in atopic dermatits

July 22, 2020
Research and Development AbbVie, atopic dermatits, pharma, upadacitinib

AbbVie has lifted the curtain on data from the second Phase 3 trial investigating the efficacy of Rinvoq (upadacitinib) monotherapy …

News
vaccinessssssssssssssssssss_1

US indicts two Chinese hackers for attempting to steal COVID-19 drug and vaccine research

July 22, 2020
Research and Development COVID-19 Vaccines, coronavirus, hacking, vaccines

Two Chinese hackers have been charged in the US with hacking medical companies and stealing hundreds of millions of dollars …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 22, 2020
Research and Development COVID-19, coronavirus

The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million …

News
shutter

Acadia’s pimavanserin falls short at Phase 3 in major depressive disorder

July 21, 2020
Manufacturing and Production, Research and Development Acadia Pharmaceuticals, major depressive disorder, phase 3, trial failure

Acadia Pharmaceuticals has lifted the lid on new Phase 3 for its therapy pimavanserin, revealing that the drug unfortunately failed …

News
vaccinessssssssssssssssssss_1

India begins human trials of its first homegrown coronavirus vaccine

July 21, 2020
Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus

India has begun human trials of its first internally developed vaccine for COVID-19. The Indian Council of Medical Research have …

News
512px-oxford_university_colleges-all_souls1

AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data

July 21, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus

Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …

News
stock_image_drugs

Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait

July 21, 2020
Manufacturing and Production COVID-19, Fujifilm, Japan, avigan, coronavirus

Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait. The trials will be …

News

North Korea says it’s developing its own coronavirus vaccine

July 21, 2020
Manufacturing and Production COVID-19, North Korea, coronavirus

North Korea has announced it is developing a vaccine against COVID-19. The announcement was made on 18 July by the …

News

Is Pharma doing enough on sustainability?

July 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …

Feature
mylan_building

Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India

July 20, 2020
Sales and Marketing COVID-19, Gilead, India, Mylan, generic, remdesivir

Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …

News
shutterstock_36423250

Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show

July 20, 2020
Research and Development, Sales and Marketing COVID-19, Synairgen

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …

News
israel

Israeli doctor tests positive for coronavirus 3 months after recovering

July 20, 2020
Sales and Marketing COVID-19, coronavirus

An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus …

News
1200px-gdpr_europe

England’s test and trace system breaks GDPR data law, according to privacy group

July 20, 2020
Sales and Marketing Contact tracing, GDPR, coronavirus, covid19

England’s test and trace programme broke General Data Protection Regulation (GDPR) data law according to the Open Rights Group (ORG). …

News
british_parliament_14749841802

UK secures early access to 90 million doses of coronavirus vaccines

July 20, 2020
Sales and Marketing COVID-19, coronaviurs, vaccines

The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.

News

Innate Pharma announces new Executive Vice President and Chief Medical Officer

July 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Innate Pharma, appointment

Innate Pharma has named Dr Joyson Karakunnel as its new Executive Vice President and Chief Medical Officer (CMO), with current …

Appointment
astrazeneca_sign_sky

AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks

July 17, 2020
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track

AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …

News
800px-smallpox_vaccine

WHO reports “alarming decline” in child vaccinations due to COVID-19 disruption

July 17, 2020
Medical Communications, Sales and Marketing COVID-19, WHO, vaccination, vaccines

The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026